Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TyRx surgical mesh

This article was originally published in Clinica

Executive Summary

TyRx Pharma has received US FDA 510(k) clearance for its bioresorbable polymer-coated surgical mesh for repairing hernias and other abdominal fascial or muscular deficiencies that require a reinforcing material to improve surgical results. The product incorporates features that the firm believes will help alleviate some of the problems associated with the use of synthetic mesh implants. It has handling characteristics that facilitate its precise placement during a surgical repair and leave less implant material following the resorption of the bioresorbable polymer coating. Less implant material should help facilitate patient comfort during the post-operative period and beyond, said the Monmouth, Junction, New Jersey firm. The mesh is scheduled for launch in the first quarter of this year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050581

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel